Mid-Term Outcomes Following TEVAR for Chronic Type B Aortic Dissection.

To evaluate the mid-term outcomes following thoracic endovascular aortic repair (TEVAR) for chronic type B aortic dissection (TBD), especially to know which re-entry closure affects the thoracic false lumen remodeling in the late chronic TBD. : From April 2017 to April 2022, 25 patients with chronic TBD underwent TEVAR. The late chronic TBD received the re-entry closure including stent-graft deployment in the renal artery, infrarenal aorta, and unilateral or bilateral iliac artery.

Impact of sarcopenia on long-term survival after cardiac surgery for end-stage renal disease patients.

Background: The long-term mortality of end-stage renal disease (ESRD) patients is still unsatisfactory. Therefore, long-term risk assessments in ESRD patients undergoing cardiac surgery are needed. Recently, sarcopenia is major concern in cardiac surgery because of its association with poor long-term survival.

Giant cardiac hemangioma in the right atrium: an asymptomatic surgical case.

Background: Cardiac hemangiomas are rare, accounting for only 5% of benign cardiac tumors. In the past, there have been few reports of giant cardiac hemangiomas that were > 100 mm in size but were asymptomatic.

Case Presentation: A 44-year-old woman presented with a large asymptomatic intracardiac mass that was accidentally detected on echocardiography.

Significant delayed aortic dilatation after tetralogy of Fallot repair: a case report.

Background: Aortic dilatation may occur in some patients even after complete repair of tetralogy of Fallot (TOF). The progression rate of the aortic diameter is so slow, and the incidence of aortic dissection is so low that it is suspected that frequent imaging of the aorta may not be necessary.

Case Presentation: We describe an asymptomatic 41-year-old man with hypertension in whom aortic dilatation was accidentally discovered 39 years after TOF repair.

Jarvik 2000 axial-flow ventricular assist device placement to a systemic morphologic right ventricle in congenitally corrected transposition of the great arteries.

Few descriptions of the implantation and management of an implantable ventricular assist device in patients with complex congenital heart disease exist in the literature. The Jarvik 2000 axial-flow ventricular assist device (Jarvik Heart, Inc., NYC, NY, USA) can be placed in either the left or the right ventricle.

[Long-term progression-free survival after reduction surgery and postoperative low-dose imatinib administration for multiple liver metastases of duodenal gastrointestinal stromal tumor].

A fifty-six year-old woman visited our institute, suffering from lower abdominal pain. A tumor was palpable in the pelvic cavity, having the diameter of 9.7 cm, as measured by transvaginal ultrasonography (US).